Competitive NMDA receptor antagonists attenuate phencyclidine-induced excitations of A10 dopamine neurons
- 24 June 1992
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 217 (1) , 1-7
- https://doi.org/10.1016/0014-2999(92)90503-v
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Effects of competitive antagonists on midbrain dopamine neurons: An electrophysiological and behavioral comparison to phencyclidineNeuropharmacology, 1991
- σ-Receptors: Implication for the control of neuronal activity of nigral dopamine-containing neuronsEuropean Journal of Pharmacology, 1991
- Non-competitive antagonists are potent activators of ventral tegmental A10 dopamine neuronsNeuroscience Letters, 1990
- Bimodal effects of phencyclidine on A10 dopamine neurons results from diverse actions at the PCP-receptor and dopamine uptake complexEuropean Journal of Pharmacology, 1990
- 3-((±)-2-Carboxypiperazin-4-yl)propyl-1-phosphonic acid (CCP) and phencyclidine produce a deficit of passive avoidance retention in ratsEuropean Journal of Pharmacology, 1990
- Phencyclidine-induced activation of ventral tegmental A10 dopamine neurons is differentially affected by lesions of the nucleus accumbens and medial prefrontal cortexLife Sciences, 1989
- Effects of phencyclidine on ventral tegmental A10 dopamine neurons in the ratNeuropharmacology, 1986
- Ketamine and phencyclidine cause a voltage-dependent block of responses to l-aspartic acidNeuroscience Letters, 1985
- The effects of phencyclidine and N-allylnormetazocine on midbrain dopamine neuronal activityEuropean Journal of Pharmacology, 1984
- The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N‐methyl‐aspartateBritish Journal of Pharmacology, 1983